Renal nerve ablation for resistant hypertension: How did we get here, present status, and future directions

Circulation

Volumn 129, Issue 13, 2014, Pages 1440-1451

  Papademetriou, Vasilios ^a   Rashidi, Amir Adel ^a   Tsioufis, Costas ^b   Doumas, Michael ^c  

^a GEORGETOWN UNIVERSITY   (United States)

^b Ippokration Genereal Hospital   (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; EFFERENT NERVE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; MALIGNANT HYPERTENSION; OVARY POLYCYSTIC DISEASE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RENAL NERVE ABLATION; RESISTANT HYPERTENSION; SENSORY NERVE; SLEEP DISORDERED BREATHING; SYMPATHETIC TONE;

CARDIOLOGY; HYPERTENSION; KIDNEY;

ANIMALS; BLOOD PRESSURE; CATHETER ABLATION; DISEASE MANAGEMENT; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; KIDNEY; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 84897427618     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.005405     Document Type: Article

References (86)

1. Bradford JR. The innervation of the renal blood vessels. J Physiol. 1889;10358-43218.
2. Author unknown. Neurosurgical treatment, indications and results (chapter 7, methods of operation). J Intern Med. 1947;127:72-76.
3. Adson AW, McCraig W, Brown GE. Surgery in its relation to hypertension. Surg Gynecol Obstet. 1936;62:314-331.
4. Weiss E. Recent advances in the pathogenesis and treatment of hypertension, a review. Psychosom Med. 1939;1:180-198.
5. Sen SK. Some observations on decapsulation and denervation of the kidney. Brit J Urol. 1936;8:319-328.
6. Papin E, Ambard L. Resection of the nerves of the kidney for nephralgia and small hydronephroses. J Urol. 1924;11:337-349.
7. Page IH, Heuer GJ. The effect of renal denervation on the level of arterial blood pressure and renal function in essential hypertension. J Clin Invest. 1935;14:27-30.
8. Page IH, Heuer GJ. The effect of renal denervation on patients suffering from nephritis. J Clin Invest. 1935;14:443-458.
9. Peet MM. Hypertension and its surgical treatment by supradiaphragmatic splanchnicectomy. Am J Surg. 1948;LXXV:48-68.
10. Smithwick RH, Thompson JE. Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc. 1953;152:1501-1504.
11. Peet MM, Woods WW, Braden S. The surgical treatment of hypertension. JAMA. 1940;115:1875-1885.
12. Freis ED, Wanko A, Wilson IM, Parrish AE. Treatment of essential hypertension with chlorothiazide (diuril); its use alone and combined with other antihypertensive agents. J Am Med Assoc. 1958;166:137-140.
13. VA Cooperative Study Group. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028-1034.
14. Wallin BG, Charkoudian N. Sympathetic neural control of integrated cardiovascular function: insights from measurement of human sympathetic nerve activity. Muscle Nerve. 2007;36:595-614.
15. Grassi G, Seravalle G, Quarti-Trevano F. The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol. 2010;95:581-586.
16. Fisher JP, Young CN, Fadel PJ. Central sympathetic overactivity: maladies and mechanisms. Auton Neurosci. 2009;148:5-15.
17. Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol. 2009;54:375-385.
18. Grassi G, Quarti-Trevano F, Seravalle G, Arenare F, Volpe M, Furiani S, Dell'Oro R, Mancia G. Early sympathetic activation in the initial clinical stages of chronic renal failure. Hypertension. 2011;57:846-851.
19. Sverrisdóttir YB, Mogren T, Kataoka J, Janson PO, Stener-Victorin E. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab. 2008;294:E576-E581.
20. Prabhakar NR, Kumar GK. Mechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxia. Respir Physiol Neurobiol. 2010;174:156-161.
21. Stadlbauer V, Stadlbauer VP, Wright GA, Banaji M, Mukhopadhya A, Mookerjee RP, Mookerjee R, Moore K, Jalan R. Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis. Gastroenterology. 2008;134:111-119.
22. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol. 2010;298:R245-R253.
23. Campese VM, Ku E, Park J. Sympathetic renal innervation and resistant hypertension. Int J Hypertens. 2011;2011:814354.
24. DiBona GF. Physiology in perspective: the wisdom of the body-neural control of the kidney. Am J Physiol Regul Integr Comp Physiol. 2005;289:R633-R641.
25. Webb RL, Brody MJ. Functional identification of the central projections of afferent renal nerves. Clin Exp Hypertens A. 1987;9(suppl 1):47-57.
26. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25(4 pt 2):878-882.
27. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med. 1992;327:1912-1918.
28. Hausberg M, Kosch M, Harmelink P, Barenbrock M, Hohage H, Kisters K, Dietl KH, Rahn KH. Sympathetic nerve activity in end-stage renal disease. Circulation. 2002;106:1974-1979.
29. Malpas SC, Evans RG. Do different levels and patterns of sympathetic activation all provoke renal vasoconstriction? J Auton Nerv Syst. 1998;69:72-82.
30. DiBona GF, Sawin LL. Effect of renal nerve stimulation on NaCl and H2O transport in Henle's loop of the rat. Am J Physiol. 1982;243:F576-F580.
31. Smyth DD, Umemura S, Pettinger WA. Renal nerve stimulation causes alpha 1-adrenoceptor-mediated sodium retention but not alpha 2-adrenoceptor antagonism of vasopressin. Circ Res. 1985;57:304-311.
32. Osborn JL, DiBona GF, Thames MD. Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation. J Pharmacol Exp Ther. 1981;216:265-269.
33. O'Hagan KP, Thomas GD, Zambraski EJ. Renal denervation decreases blood pressure in DOCA-treated miniature swine with established hypertension. Am J Hypertens. 1990;3:62-64.
34. Huang WC, Fang TC, Cheng JT. Renal denervation prevents and reverses hyperinsulinemia-induced hypertension in rats. Hypertension. 1998;32:249-254.
35. Schauerte P, Scherlag BJ, Scherlag MA, Goli S, Jackman WM, Lazzara R. Ventricular rate control during atrial fibrillation by cardiac parasympathetic nerve stimulation: a transvenous approach. J Am Coll Cardiol. 1999;34:2043-2050.
36. Schauerte P, Scherlag BJ, Pitha J, Scherlag MA, Reynolds D, Lazzara R, Jackman WM. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation. 2000;102:2774-2780.
37. Persell SD. Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension. 2011;57:1076-1080.
38. De la Sierra A, Segura J, Banegas JR, Gorostidi M, De la Cruz JJ, Armario P, Oliveras A, Ruilope LM. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57:898-902.
39. Doumas M, Douma S. Renal sympathetic denervation: the jury is still out. Lancet. 2010;376:1878-1880.
40. Atherton DS, Deep NL, Mendelsohn FO. Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat. 2012;25:628-633.
41. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-1281.
42. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-1909.
43. Doumas M, Anyfanti P, Bakris G. Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. J Hypertens. 2012;30:874-876.
44. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens. 2004;22:435-445.
45. Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Papademetriou V. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J. 2013;34:2132-2140.
46. Papademetriou V, Tsioufis C, Worthley M, Chew D, Meredith I, Malaiapan Y, Sinhal A, Worthley SG. Percutaneous sympathetic renal denervation in patients with drug-resistant hypertension: results from the EnligHTN, first-in-human multi-center study. J Clin Hypertens. 2013;15:516-517.
47. Witkowski A, Prejbisz A, Florczak E, Kdziela J, liwiski P, Biele P, Michałowska I, Kabat M, Warchoł E, Januszewicz M, Narkiewicz K, Somers VK, Sobotka PA, Januszewicz A. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58:559-565.
48. Hering D, Mahfoud F, Walton AS, Krum H, Lambert GW, Lambert EA, Sobotka PA, Böhm M, Cremers B, Esler MD, Schlaich MP. Renal denervation in moderate to severe CKD. J Am Soc Nephrol. 2012;23:1250-1257.
49. Ormiston JA, Watson T, van Pelt N, Stewart R, Stewart JT, White JM, Doughty RN, Stewart F, Macdonald R, Webster MW. Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trial. EuroIntervention. 2013;9:70-74.
50. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation. 2013;128:132-140.
51. Parati G, Ochoa JE, Bilo G. Renal sympathetic denervation and daily life blood pressure in resistant hypertension: simplicity or complexity Circulation. 2013;128:315-317.
52. Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE. Renal denervation in moderate treatment-resistant hypertension. J Am Coll Cardiol. 2013;62:1880-1886.
53. Lacourcière Y, Crikelair N, Glazer RD, Yen J, Calhoun DA. 24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension. J Hum Hypertens. 2011;25:615-622.
54. Mahfoud F, Cremers B, Janker J, Link B, Vonend O, Ukena C, Linz D, Schmieder R, Rump LC, Kindermann I, Sobotka PA, Krum H, Scheller B, Schlaich M, Laufs U, Böhm M. Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension. 2012;60:419-424.
55. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911-917.
56. Head GA, Mihailidou AS, Duggan KA, Beilin LJ, Berry N, Brown MA, Bune AJ, Cowley D, Chalmers JP, Howe PR, Hodgson J, Ludbrook J, Mangoni AA, McGrath BP, Nelson MR, Sharman JE, Stowasser M; Ambulatory Blood Pressure Working Group of the High Blood Pressure Research Council of Australia. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ. 2010;340:c1104.
57. Brinkmann J, Heusser K, Schmidt BM, Menne J, Klein G, Bauersachs J, Haller H, Sweep FC, Diedrich A, Jordan J, Tank J. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficultto-control hypertensive patients: prospective case series. Hypertension. 2012;60:1485-1490.
58. Mahfoud F, Böhm M, Rump LC, Vonend O, Schmieder RE, Kintscher U. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series. Hypertension. 2013;61:e17.
59. Schlaich M, Hering D, Lambert G, Lambert E, Esler M. Blood pressure and sympathetic nervous system response to renal denervation. Hypertension. 2013;61:e13.
60. Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study. Catheter Cardiovasc Interv. 2013;81:335-339.
61. Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C; European Society of Hypertension. Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention. 2013;9(suppl R):R58-R66.
62. Mahfoud F, Lüscher TF, Andersson B, Baumgartner I, Cifkova R, Dimario C, Doevendans P, Fagard R, Fajadet J, Komajda M, Lefèvre T, Lotan C, Sievert H, Volpe M, Widimsky P, Wijns W, Williams B, Windecker S, Witkowski A, Zeller T, Böhm M; European Society of Cardiology. Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J. 2013;34:2149-2157.
63. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension. 2013;61:457-464.
64. Tsioufis C, Papademetriou V, Dimitriadis K, Tsiachris D, Thomopoulos C, Park E, Hata C, Papalois A, Stefanadis C. Catheter-based renal sympathetic denervation exerts acute and chronic effects on renal hemodynamics in swine. Int J Cardiol. 2013;168:987-992.
65. Chinushi M, Izumi D, Iijima K, Suzuki K, Furushima H, Saitoh O, Furuta Y, Aizawa Y, Iwafuchi M. Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery. Hypertension. 2013;61:450-456.
66. Ukena C, Mahfoud F, Spies A, Kindermann I, Linz D, Cremers B, Laufs U, Neuberger HR, Böhm M. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. Int J Cardiol. 2013;167:2846-2851.
67. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
68. Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J, Hamady M, Hughes AD, Sever PS, Sobotka PA, Francis DP. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol. 2013;162:189-192.
69. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, Böhm M, Hoppe UC. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59:901-909.
70. Papademetriou V, Doumas M, Anyfanti P, Faselis C, Kokkinos P, Tsioufis K. Renal nerve ablation for hypertensive patients with chronic kidney disease [published online ahead of print July 31, 2013]. Curr Vasc Pharmacol. doi: 10.2174/15701611113119990143. http://www.eurekaselect. com/113766/article. Accessed March 10, 2014.
71. Schlaich M. Sustained reduction of central sympathetic outflow after renal denervation in end stage renal disease. J Hypertens. 2011;29:e103.
72. Prochnau D, Lauten A, Busch M, Kuehnert H, Figulla HR, Surber R. Catheter-based radiofrequency ablation therapy of the renal sympatheticnerve system for drug resistant hypertension in a patient with end-stage renal disease. Int J Cardiol. 2012;154:e29-e30.
73. Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol. 2013;168:2214-2220.
74. Dörr O, Liebetrau C, Möllmann H, Achenbach S, Sedding D, Szardien S, Willmer M, Rixe J, Troidl C, Elsässer A, Hamm C, Nef HM. Renal sympathetic denervation does not aggravate functional or structural renal damage. J Am Coll Cardiol. 2013;61:479-480.
75. Petidis K, Anyfanti P, Doumas M. Renal sympathetic denervation: renal function concerns. Hypertension. 2011;58:e19; author reply e20.
76. Shetty SV, Roberts TJ, Schlaich MP. Percutaneous transluminal renal denervation: a potential treatment option for polycystic kidney diseaserelated pain Int J Cardiol. 2013;162:e58-e59.
77. de Beus E, Blankestijn PJ, Fox JG, Zoccali C. Catheter-based renal denervation as a novel treatment for loin pain haematuria syndrome. Nephrol Dial Transplant. 2013;28:2197-2199.
78. Doumas M, Faselis C, Tsioufis C, Papademetriou V. Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure. Curr Hypertens Rep. 2012;14:238-246.
79. Tsioufis K, Papademetriou V, Tsiachris D, Dimitriadis K, Thomopoulos C, Kefala A, Stefanadis C. Renal sympathetic denervation significantly reduces mean heart rate and exerts a favorable effect on atrial and ventricular arrhythmias in resistant hypertensives. J Am Coll Cardiol. 2013;61:E1376.
80. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K, Böhm M. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60:172-178.
81. Zhao Q, Yu S, Zou M, Dai Z, Wang X, Xiao J, Huang C. Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol. 2012;35:119-125.
82. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A, Shirokova N, Karaskov A, Mittal S, Steinberg JS. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol. 2012;60:1163-1170.
83. Ukena C, Bauer A, Mahfoud F, Schreieck J, Neuberger HR, Eick C, Sobotka PA, Gawaz M, Böhm M. Renal sympathetic denervation for treatment of electrical storm: first-in-man experience. Clin Res Cardiol. 2012;101:63-67.
84. Franquini JV, Medeiros AR, Andrade TU, Araújo MT, Moysés MR, Abreu GR, Vasquez EC, Bissoli NS. Influence of renal denervation on blood pressure, sodium and water excretion in acute total obstructive apnea in rats. Braz J Med Biol Res. 2009;42:214-219.
85. Schlaich MP, Straznicky N, Grima M, Ika-Sari C, Dawood T, Mahfoud F, Lambert E, Chopra R, Socratous F, Hennebry S, Eikelis N, Böhm M, Krum H, Lambert G, Esler MD, Sobotka PA. Renal denervation: a potential new treatment modality for polycystic ovary syndrome J Hypertens. 2011;29:991-996.
86. Mahfoud F, Schlaich M, Kindermann I, Ukena C, Cremers B, Brandt MC, Hoppe UC, Vonend O, Rump LC, Sobotka PA, Krum H, Esler M, Böhm M. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation. 2011;123:1940-1946.